FDAFDA · Food and drugs·Recall number D-1540-2022
PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Published September 21, 2022 · Recall initiated: August 22, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- PROPOFOL
- Manufacturer
- Pfizer Inc.
- Distributor
- USA Nationwide
- Lot
- Lot#: EA7470, Exp 6/1/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.